🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/12/2019 | 68,86 | 69,84 | 68,13 | 69,25 | -0,36% | 2,48% | 706.602 |
| 02/12/2019 | 70,71 | 71,05 | 69,01 | 69,50 | -1,41% | 2,89% | 404.437 |
| 29/11/2019 | 70,62 | 71,38 | 70,38 | 70,49 | +0,12% | 1,41% | 187.872 |
| 27/11/2019 | 70,70 | 71,42 | 69,95 | 70,41 | +0,28% | 2,08% | 295.433 |
| 26/11/2019 | 69,90 | 70,49 | 69,19 | 70,21 | +0,30% | 1,87% | 272.029 |
| 25/11/2019 | 69,08 | 70,21 | 68,50 | 70,00 | +2,14% | 2,48% | 485.549 |
| 22/11/2019 | 68,40 | 68,88 | 67,57 | 68,53 | +0,69% | 1,92% | 808.714 |
| 21/11/2019 | 66,11 | 68,22 | 65,46 | 68,07 | +3,66% | 4,17% | 638.635 |
| 20/11/2019 | 64,32 | 66,16 | 63,94 | 65,66 | +1,44% | 3,45% | 529.471 |
| 19/11/2019 | 65,05 | 65,81 | 64,17 | 64,73 | +0,25% | 2,53% | 415.979 |
| 18/11/2019 | 67,37 | 67,42 | 63,94 | 64,57 | -3,97% | 5,16% | 804.065 |
| 15/11/2019 | 66,05 | 67,42 | 65,15 | 67,24 | +2,83% | 3,43% | 587.339 |
| 14/11/2019 | 68,36 | 69,40 | 65,23 | 65,39 | -4,70% | 6,10% | 730.487 |
| 13/11/2019 | 67,09 | 69,39 | 66,38 | 68,62 | +1,40% | 4,50% | 565.859 |
| 12/11/2019 | 67,87 | 69,23 | 67,11 | 67,67 | -0,39% | 3,12% | 531.234 |
| 11/11/2019 | 67,02 | 68,40 | 65,72 | 67,94 | +0,09% | 4,00% | 570.828 |
| 08/11/2019 | 63,04 | 67,87 | 62,54 | 67,87 | +7,05% | 8,46% | 804.866 |
| 07/11/2019 | 64,76 | 67,15 | 62,65 | 63,40 | -0,52% | 6,96% | 1.040.828 |
| 06/11/2019 | 67,37 | 67,38 | 62,08 | 63,73 | -8,57% | 7,87% | 1.782.215 |
| 05/11/2019 | 69,29 | 70,49 | 68,97 | 69,70 | +1,27% | 2,20% | 538.127 |
| 04/11/2019 | 70,32 | 70,68 | 68,65 | 68,83 | -1,96% | 2,89% | 321.241 |
| 01/11/2019 | 68,20 | 70,29 | 68,00 | 70,21 | +3,43% | 3,35% | 447.077 |
| 31/10/2019 | 68,65 | 69,10 | 66,76 | 67,88 | -1,72% | 3,41% | 416.780 |
| 30/10/2019 | 70,07 | 70,41 | 68,54 | 69,06 | -1,70% | 2,67% | 500.296 |
| 29/10/2019 | 70,76 | 71,04 | 69,89 | 70,26 | -0,85% | 1,63% | 342.561 |
| 28/10/2019 | 69,59 | 71,07 | 69,36 | 70,86 | +2,03% | 2,46% | 386.644 |
| 25/10/2019 | 67,72 | 69,88 | 67,72 | 69,45 | +1,58% | 3,18% | 292.868 |
| 24/10/2019 | 69,30 | 69,69 | 67,87 | 68,37 | -0,50% | 2,63% | 450.122 |
| 23/10/2019 | 68,88 | 69,98 | 68,62 | 68,71 | -0,63% | 1,98% | 383.277 |
| 22/10/2019 | 68,40 | 69,68 | 68,19 | 69,15 | +2,10% | 2,17% | 388.407 |